M&A Deal Summary |
|
|---|---|
| Date | 2016-08-30 |
| Target | Accuratus Lab Services |
| Sector | Medical Products |
| Buyer(s) | Analytical Lab Group |
| Sellers(s) | Ampersand Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2006 |
| Sector | Test/Measurement Equipment |
Analytical Lab Group is an independent provider of materials and product qualification testing, inspection and certification services to the global Aerospace; Transportation & Industrials; Energy; and Fire & Building Products sectors. Analytical Lab Group was formed in 2006 and is based in Eagan, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Medical Products) | 1 of 1 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Minnesota) | 1 of 1 |
| Country (United States) | 1 of 2 |
| Year (2016) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-09-27 |
Microbiology & Quality Associates
Concord, California, United States Microbiology & Quality Associates, Inc. is a biotechnology company offering testing laboratories, validation, calibration, and manufacturing services. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 2.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 53 |
| Sector (Medical Products) | 9 of 14 |
| Type (Add-on Acquisition) | 21 of 38 |
| State (Minnesota) | 3 of 3 |
| Country (United States) | 30 of 50 |
| Year (2016) | 8 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-08-22 |
BioClinica
Princeton, New Jersey, United States Bioclinica is an integrated clinical life science solutions provider, delivering powerful insight into clinical trial development, assuring greater client success in bringing medical therapies to market, for people around the world. Through deep medical, scientific, and technology expertise, the company provides medical imaging and cardiac safety services; clinical adjudication; randomization and trial supply management and optimization; electronic and eSource data capture; site and patient payments; clinical trial management software; and drug safety solutions. Bioclinica’s global team of life science experts serves more than 500 pharmaceutical, biotechnology, and device organizations including the top 20 biopharmaceutical companies and leading CROs through offices in North America, Europe, and Asia. Bioclinica was formed in 1990 and is based in Princeton, New Jersey. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-09-28 |
Agilux Laboratories
Worcester, Massachusetts, United States Agilux Laboratories, Inc. is a provider of integrated discovery small and large molecule bioanalytical services, drug metabolism and pharmacokinetic (DMPK) services, and pharmacology services. |
Sell | $64M |
